STACEY WOLKING, et al. v. HENRY LINDNER, M.D., et al.
CIVIL ACTION NO. 3:23-CV-806
UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF PENNSYLVANIA
April 14, 2025
SAPORITO, J.
MEMORANDUM
This is an action by the plaintiffs, Stacy and Daryl Wolking, against the defendant, Youngs Apothecary, Inc. d/b/a Tunkhannock Compounding Center (“TCC“), related to its dispensing of medical prescriptions to Ms. Wolking. Now, before the court is TCC‘s motion in limine for bifurcation of liability and damages at trial. (Doc. 87). The plaintiffs have timely filed a brief in opposition (Doc. 119), and on April 10, 2025, the Court heard oral arguments from both parties concerning the matter. It is now ripe for review.
I. Background
Because we write for the parties only, we shall briefly outline the factual history of this case. In 2022, the plaintiff was treated by defendant Henry Lindner, M.D. (“Dr. Lindner“) for what he diagnosed as
II. Legal Standard
III. Discussion
The Third Circuit has recognized that in similar cases “bifurcating a trial into separate liability and damages sections is the exception, not the rule.” Sweigart v. Voyager Trucking Corp., No. 23-2397, 2024 WL 3565306, at *3 (3d Cir. July 29, 2024), cert. denied sub nom. Patten v. Sweigart, No. 24-585, 2025 WL 76499 (U.S. Jan. 13, 2024). After analyzing the record and weighing each party‘s contentions in this case, we find that TCC has failed to meet its burden in persuading us that bifurcation is needed.
Here, TCC does not address all four factors concerning bifurcation within its brief. It only argues that bifurcation is appropriate to avoid prejudice and to facilitate judicial economy. (Doc. 87, at 7). TCC does not articulate what prejudice it may suffer with a denial of its motion. Moreover, we find that its brief chiefly focuses on judicial economy, rather than prejudice. However, a request for a motion to bifurcate on the basis of judicial economy is not enough. Courts must consider four factors, not just one, when deciding whether to grant a motion to bifurcate. See
After analyzing all four factors in light of the record, we find the plaintiffs’ argument persuasive. First, the contested issues of liability and damages in this case are not significantly different. This case represents the majority of negligence cases where liability and damages are inherently intertwined. See (Doc. 119 at 5) (“[T]he question of liability depends upon the harm that the drugs can cause.“). Due to that nature, both issues concern the use of similar evidence, witnesses, and documents. See (Id. at 6) (arguing that the trial concerns multiple overlapping documents and witnesses). Moreover, we find that bifurcation will unnecessarily prolong and complicate the judicial process, thereby inhibiting judicial economy. As we stated above, the evidence and arguments introduced by both parties are interlinked, and the separation of liability and damages risks further complicating the case for the jury. See Robinson v. Nationwide Mut. Ins. Co., No. CIV.A. 12-5065, 2013 WL 686352, at *5 (E.D. Pa. Feb. 26, 2013) (quoting Enzo Life Sciences, Inc. v. Digene Corp., No. CIV.A. 02-212, 2003 WL 21402512, at *4 (D. Del. June 10, 2003)) (“Courts, when exercising their broad discretion to bifurcate issues for trial under
IV. Conclusion
For these reasons, we will deny the TCC‘s motion to bifurcate the issues of liability and damages at trial.
An appropriate order follows.
Dated: April 14, 2025
s/Joseph F. Saporito, Jr.
JOSEPH F. SAPORITO, JR.
United States District Judge
